{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P51587",
      "entity_text" : "BRCA2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0591" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Therefore, NMD mechanism recognizes PTCs in BRCA2 transcripts and leads to their degradation.16 Reduced BRCA2 levels are associated with cancer, as loss of either BRCA allele is frequently observed in breast cancer tumors of BRCA1 and BRCA2 mutation carriers.2 BRCA2 variant 7655_7658delTTAA was previously reported in the ClinVar database in Polish, Chinese and New Zealander breast cancer patients.17, 18 Now, we report that this pathogenic variant is also found in a Turkish breast cancer family.",
  "reading_complete" : "2020-08-02T11:57:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:56:50Z",
  "trigger" : "levels",
  "evidence" : [ "BRCA2 levels" ],
  "pmc_id" : "6132100",
  "score" : 0
}